Supplementary Figure 1 from p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy
Myrthala Moreno‐Smith(Gynecologic Oncology Group), Eveline Barbieri(Children's Cancer Center), Silke Paust(Scripps Research Institute), Kevin Aviles-Padilla(Baylor College of Medicine), Jason M. Shohet(University of Massachusetts Chan Medical School), Rana Nikzad(Scripps Research Institute), Anna Lakoma(Baylor College of Medicine), Vivien Sheehan(Emory University), Linda Schild(Amsterdam UMC Location University of Amsterdam), Zaowen Chen(Children's Cancer Center), Jan J. Molenaar(Princess Máxima Center), Kathleen A. Scorsone(Children's Cancer Center), Sanjeev A. Vasudevan(Baylor College of Medicine), Eugene S. Kim(Cedars-Sinai Medical Center), Ling Tao(Children's Hospital of Fudan University), Yankai Zhang(Parker University), Rikhia Chakraborty(Cleveland State University)
Cited by 0
Related Papers
Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
|Nature Immunology|2010|690
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation
|Nature|2014|592
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
|Proceedings of the National Academy of Sciences|2004|321
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
|Proceedings of the National Academy of Sciences|2002|313
Natural killer cell memory
|Nature Immunology|2011|234